Related Experiment Video
Updated: Dec 23, 2025
09:19
Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma
Published on: July 14, 2022
4.0K
Necroptosis in Cholangiocarcinoma
Samantha Sarcognato1, Iris E M de Jong2, Luca Fabris3
1Department of Pathology, Azienda ULSS2 Marca Trevigiana, 31100 Treviso, Italy.
Cells
|April 25, 2020
Summary
Necroptosis, a programmed cell death pathway, plays a complex role in cancer. Targeting necroptosis offers promising therapeutic strategies for liver biliary neoplasms.
Area of Science:
- Cell Biology
- Immunology
- Oncology
Background:
- Necroptosis is a regulated cell death pathway implicated in various pathologies.
- It is triggered by death receptors and regulated by RIPK1/3 and MLKL, forming the necrosome.
- Necroptosis acts as an alternative to apoptosis and can promote anti-tumor immunity.
Purpose of the Study:
- To review the current understanding of necroptosis.
- To explore the role of necroptosis in liver biliary neoplasms.
- To highlight the therapeutic potential of targeting necroptosis in cancer treatment.
Main Methods:
- Literature review of necroptosis.
- Analysis of necroptosis's role in cancer, specifically liver biliary neoplasms.
- Discussion of therapeutic strategies targeting necroptosis.
Main Results:
- Necroptosis has a context-dependent role in cancer, potentially inhibiting tumor progression.
- It can overcome apoptosis resistance and elicit anti-tumor CD8+ T cell responses.
- Targeting necroptosis components shows promise for anti-cancer therapy.
Conclusions:
- Necroptosis is a significant pathway in liver biliary neoplasms.
- Modulating necroptosis presents a viable strategy for developing novel cancer treatments.
- Further research into necroptosis-targeting therapies is warranted.
